Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

(2014) Kai Liu et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model

(2014) Beibei Luo et al.   PLoS One

Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors

(2013) Qian Yong et al.   Cardiovascular Diabetology

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

(2013) Ali Movahed et al.   Evidence-based Complementary and Alternative Medicine

Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions

(2013) Dogan Erdogan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

(2012) João Tomé-Carneiro et al.   AMERICAN JOURNAL OF CARDIOLOGY

Resveratrol provoca efeitos antiaterogênicos em um modelo animal de aterosclerose

(2012) Rômulo Dias Novaes et al.   Arquivos Brasileiros de Cardiologia

Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor

(2012) Candice M. Thomas et al.   CLINICAL SCIENCE

Long-term oral Asperosaponin VI attenuates cardiac dysfunction, myocardial fibrosis in a rat model of chronic myocardial infarction

(2012) Chunmei Li et al.   FOOD AND CHEMICAL TOXICOLOGY

Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats

(2011) Arun Prasath Lakshmanan et al.   BIOCHEMICAL PHARMACOLOGY

Reduced Adipose Tissue Inflammation Represents an Intermediate Cardiometabolic Phenotype in Obesity

(2011) Melissa G. Farb et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes

(2010) Agnieszka Biala et al.   BLOOD PRESSURE

Medicinal Chemistry of Drugs Used in Diabetic Cardiomyopathy

(2010) E. Adeghate et al.   CURRENT MEDICINAL CHEMISTRY

Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis

(2010) A. Borriello et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

(2009) E. Gava et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts

(2008) Kaliyamurthi Venkatachalam et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells

(2008) Ryohei Miyazaki et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY